Personal Health Record Apps: Helping Patients Keep Records
How Indian clinics can help patients keep their own health records: ABHA and PHR apps, consent-based sharing, paper and PDF options and privacy.
How doctors in India use drug reference apps and interaction checkers safely: choosing sources, Indian brands, FDC bans, alert fatigue and reporting reactions.
Digital drug references and interaction checkers help doctors confirm doses, contraindications, interactions and Indian brand names at the point of prescribing. Use sources with clear editorial review and update dates, check that Indian brands and fixed-dose combinations map to the right ingredients, be aware of drugs and combinations banned by CDSCO, treat interaction alerts as prompts for judgement rather than orders, avoid entering identifiable patient data into consumer apps, and report suspected adverse reactions to the Pharmacovigilance Programme of India.
Indian doctors prescribe from thousands of brands, many of them fixed-dose combinations, and patients often take medicines from several doctors and chemists at once. A quick check of dose, renal adjustment, pregnancy safety or interactions takes seconds on a phone or computer and can prevent harm. Printed references go out of date; digital ones can be updated, but only if the publisher actually does so.
This guide is general information. Clinical decisions remain the prescribing doctor's responsibility.
On a narrow screen, scroll the table sideways to see every column.
| Type | Use | Watch for |
|---|---|---|
| National reference, such as the National Formulary of India | Standard doses, cautions, interactions for medicines used in India | Update frequency; check the edition |
| Drug brand databases | Find ingredients and strengths behind Indian brands | Accuracy of brand-to-ingredient mapping |
| Interaction checkers | Check combinations of several drugs | Over-alerting and missing Indian FDCs |
| Paediatric dosing tools | Weight-based doses | Units, formulations and maximum doses |
| Renal and hepatic dosing references | Dose adjustment | Use current kidney function, not old values |
| Pregnancy and lactation references | Safety of medicines | Evidence changes; check dates |
| Prescribing software with built-in checks | Alerts while prescribing | Which reference powers it, and when it was updated |
Be cautious with apps funded mainly by pharmaceutical advertising, which may favour particular brands.
Many interaction checkers are built for international markets and may not recognise Indian brand names or combinations. Always check that the tool maps the brand to the right ingredients and strengths. CDSCO has banned many fixed-dose combinations over the years; check the current list before prescribing an unfamiliar combination. Prescribing by generic name, as professional conduct rules encourage, also makes interaction checks easier.
Interaction checkers often show many low-importance alerts. Doctors then learn to click past all of them, including the dangerous ones. Look for tools that grade severity and let you focus on major interactions. When an alert appears, think about the patient in front of you: dose, duration, kidney and liver function, age and other conditions. Document your decision when you go ahead despite a major alert.
Many consumer drug apps collect data about searches and users. Avoid entering patient names, phone numbers or other identifying details into apps that are not part of the clinic's records system. Under the DPDP Act, patient data should be shared only for a clear purpose with appropriate safeguards. A drug name and dose alone, without patient identifiers, is usually enough for a reference check.
AI assistants can summarise drug information quickly, but they can also produce confident errors. Use them, if at all, as a starting point and confirm doses and interactions in a reliable reference. Never paste identifiable patient details into general AI tools.
When you suspect an adverse drug reaction, report it to the Pharmacovigilance Programme of India, run by the Indian Pharmacopoeia Commission. Reports from practising doctors help detect safety problems with medicines used in India. Record the reaction in the patient's record and tell the patient.
The most useful reference is the one you will actually open during a busy OPD. Keep one or two trusted sources bookmarked on each consultation computer and phone. Agree as a clinic which references to use, so doctors and staff give consistent advice. A shared clinic formulary listing preferred medicines, doses and common interactions can save time for common prescriptions.
A general practitioner seeing many elderly patients found that several were taking medicines prescribed by different specialists, some with overlapping ingredients hidden behind brand names. He began asking patients to bring all their medicine strips, checked brand ingredients in a drug database, and ran the combination through an interaction checker that grades severity. In one month he found three patients taking two brands of the same painkiller and one patient on a combination with a major bleeding risk. He documented each change and wrote to the other doctors.
Some patients need a reference check for almost every prescription. Children need weight-based doses and suitable formulations. Older adults often take five or more medicines and are more sensitive to sedatives, anticholinergics and drugs that affect the kidneys. Pregnant and breastfeeding women need safety checks that change as evidence grows. Patients with kidney or liver disease need dose adjustment based on current results, not old reports. Building a habit of checking for these groups catches most serious errors, and a quick note in the record shows that the check was done.
Bractis supports safer prescribing with clear, legible prescriptions and the visit history in one place. For built-in drug references and interaction checks, ask the team what is supported today and test it with your common prescriptions.
Use sources with clear editorial review and recent updates that cover Indian medicines, such as the National Formulary of India, alongside trusted clinical references.
Some are, but check who writes the content, when it was updated and whether advertising influences it.
Not always. Check that the brand maps to the right ingredients.
Report it to the Pharmacovigilance Programme of India through its reporting form or app.
Bractis is clinic management software built for Indian OPDs: appointments, patient records, prescriptions, billing and follow-up in one place. You can try it in your own clinic before you decide.
Written by the Bractis editorial team for doctors and clinic owners in India. Rules, fees and prices change: check the linked primary sources before acting, and ask your CA or lawyer about your own case.
Reference on medicines used in India, including doses, contraindications, interactions and cautions.
National programme for reporting suspected adverse drug reactions, including by doctors.
Drug approvals, banned fixed-dose combinations, safety alerts and medical device regulation.
Confidentiality, records and ethical duties of doctors.
Duties of data fiduciaries, including consent, purpose limits, reasonable security safeguards and breach intimation.
How Indian clinics can help patients keep their own health records: ABHA and PHR apps, consent-based sharing, paper and PDF options and privacy.
Where chatbots help Indian clinics, such as bookings, timings and reminders, where they must stop, and how to follow NMC, telemedicine and data protection rules.
What Indian doctors should know about CME: the ethical duty, state council credit rules for renewal, accredited programmes, online CME and a simple tracking system.
How doctors in India secure the phone they use for patients: screen lock, updates, WhatsApp settings, clinical photos, app permissions and lost phones.